EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy

Anne-Laure Mallard de La Varende, Ai-Ling Tian, Simon Thomas, Imran Lahmar, Meriem Messaoudene, Sijing Li, Omar Motiño, Hortense Guillaume-Dit-Taunière, Valerio Iebba, Yoan Hurtado, Thao-Nguyen Pham, Cassandra Thélémaque und 43 weitere

Cancer Cell · 2026-08 · 44 (8) · 1653-1671.e16

DOI: 10.1016/j.ccell.2026.06.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-08. Verfasst von Anne-Laure Mallard de La Varende und 54 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Gustave Roussy (GRCC), ClinicObiome, Inserm UMR1367, Microbiota and Mucosal Immunity for Cancer Immunotherapy, 94805 Villeju…. Hauptthemen laut MEDLINE: Dysbiosis, Immunotherapy, Cholestasis, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, FRQS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisImmunotherapyCholestasisNeoplasmsGastrointestinal MicrobiomeDrug Resistance, NeoplasmAnimalsHumansMiceBile Acids and SaltsAnti-Bacterial AgentsFemaleMaleT-Cell Exhaustion

Stichwörter der Autor:innen

MAdCAM-1PD-1antibioticsbile acidscancergut microbiotaimmune checkpoint blockadeimmunotherapymicrobiomemucosal addressin cell adhesion molecule 1

Substanzen

Bile Acids and SaltsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Université Paris-Saclay, Gustave Roussy (GRCC), ClinicObiome, Inserm UMR1367, Microbiota and Mucosal Immunity for Cancer Immunotherapy, 94805 Villejuif, France.
  • Centre de recherche Du CHUM (CRCHUM), Montréal, QC H2W1T8, Canada.
  • Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale Contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France.
  • Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale Contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France; Unidad de Excelencia, Instituto de Biomedicina y G…
  • MetaGenoPolis, INRAe, Université Paris-Saclay 78350 Jouy en Josas, France.
  • Université Paris-Saclay, INSERM US23, Analyse moléculaire, modélisation et imagerie de la maladie Cancéreuse, Plateformes de Métabolomique et de Criblage Cellulaire Haut Débit, 94805 Villejuif, France.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • FRQS
  • Horizon 2020
  • European Research Council
  • Paris-Saclay University
  • Regione Lombardia
  • Fondazione AIRC per la Ricerca sul Cancro ETS

Zitieren

APA

Mallard de La Varende, A. L., Tian, A. L., Thomas, S., Lahmar, I., Messaoudene, M., Li, S., Motiño, O., Guillaume-Dit-Taunière, H., Iebba, V., Hurtado, Y., Pham, T. N., Thélémaque, C., Araujo-Voces, M., Suissa, D., Ly, P., Reich, E., Vitali, G., Arlunno, B. T., Durand, S., …, & Zitvogel, L. (2026). Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy. Cancer Cell, 44(8), 1653-1671.e16. https://doi.org/10.1016/j.ccell.2026.06.022

Vancouver

Mallard de La Varende AL, Tian AL, Thomas S, Lahmar I, Messaoudene M, Li S, et al. Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy. Cancer Cell. 2026;44(8):1653-1671.e16. doi:10.1016/j.ccell.2026.06.022

BibTeX
@article{MallarddeLaVarende2026,
  author = {Mallard de La Varende, Anne-Laure and Tian, Ai-Ling and Thomas, Simon and Lahmar, Imran and Messaoudene, Meriem and Li, Sijing and Motiño, Omar and Guillaume-Dit-Taunière, Hortense and Iebba, Valerio and Hurtado, Yoan and Pham, Thao-Nguyen and Thélémaque, Cassandra and Araujo-Voces, Miguel and Suissa, Deborah and Ly, Pierre and Reich, Ella and Vitali, Giacomo and Arlunno, Bryan Thierry and Durand, Sylvere and Aprahamian, Fanny and Leduc, Marion and Forveille, Sabrina and Kepp, Oliver and de la Calle-Fabregat, Carlos and Schippers, Angela and Wagner, Norbert and Fournier, Pierre-Edouard and Honda, Kenya and Marmorino, Federica and Cremolini, Chiara and Maleki Vareki, Saman and Lenehan, John G and Marabelle, Aurélien and Danlos, François-Xavier and Deligne, Margaux and Truntzer, Caroline and Ghiringhelli, François and Ree, Anne H and Bousquet, Paula A and Meltzer, Sebastian and Ginhoux, Florent and Rummel, Deklan and Fu, Yousi and Quinn, Robert A and Alves Costa Silva, Carolina and Iacovelli, Roberto and Ciccarese, Chiara and Porcari, Serena and Elkrief, Arielle and Routy, Bertrand and Ianiro, Gianluca and Derosa, Lisa and Kroemer, Guido and Fidelle, Marine and Zitvogel, Laurence},
  title = {Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {8},
  pages = {1653--1671.e16},
  doi = {10.1016/j.ccell.2026.06.022}
}
Kostenlos starten →